白血病抑制因子(LIF)单克隆抗体
Monoclonal Antibody to Leukemia Inhibitory Factor (LIF)
CDF; D-FACTOR; HILDA; MLPLI; Cholinergic Differentiation Factor; Differentiation-Stimulating Factor; Melanoma-Derived LPL Inhibitor; Emfilermin
- 编号MAA085Hu22
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源单抗制备
- 宿主小鼠
- 效价(克隆号)C1
- Ig亚型 IgG1 Kappa
- 纯化方式蛋白A + 蛋白G亲和纯化
- 标记物无标记物
- 免疫原 RPA085Hu01-白血病抑制因子(LIF)重组蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性状液体
- 浓度1mg/mL
- 且适物种Sus scrofa; Porcine (Pig，猪)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 522 ¥ 1218 ¥ 1740 ¥ 4350 ¥ 17400
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
DAB staining on IHC-P; Samples: Human Pancreas Tissue; Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody
Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Samples: Human Small intestine Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody
Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Samples: Human Skeletal muscle Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human LIF Antibody
Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Figure. Western Blot; Sample: Recombinant LIF, Human.
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对LIF的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别LIF。
用法
Western blotting: 0.5-3µg/mL;
Immunohistochemistry: 5-30µg/mL;
Immunocytochemistry: 5-30µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| APA085Hu61 | 白血病抑制因子(LIF)活性蛋白 | Cell culture; Activity Assays. |
| RPA085Hu01 | 白血病抑制因子(LIF)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA085Hu61 | 白血病抑制因子(LIF)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA085Hu01 | 白血病抑制因子(LIF)活性蛋白 | Cell culture; Activity Assays. |
| PAA085Hu01 | 白血病抑制因子(LIF)多克隆抗体 | WB; IHC |
| MAA085Hu22 | 白血病抑制因子(LIF)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA085Hu21 | 白血病抑制因子(LIF)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA085Hu23 | 白血病抑制因子(LIF)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA085Hu24 | 白血病抑制因子(LIF)单克隆抗体 | WB; IHC; ICC; IP. |
| SEA085Hu | 白血病抑制因子(LIF)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA085Hu | 白血病抑制因子(LIF)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| British Journal of Anaesthesia | Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids [pubmed:28077540] |
| Biological Rhythm Research | A study of altered cytokine rhythms associated with successful implantation in cows [10.1080/09291016.2017.1361159] |
| Integrated analysis of cancer stem cells-associated lncRNA-miRNA-mRNA network for ovarian cancer via microarray and Gene Expression Omnibus database [] |
留言咨询